“…Overexpression of the EGF receptor has been shown to correlate with metastasis and poor prognosis in a number of tumor types, including small-cell lung cancer, breast cancer, gastric cancer, and prostate cancer (16 -19). Cell lines that overexpress EGF receptors also are more metastatic in vivo (20), and experimental expression of the EGF receptor in nonmetastatic cells increases their chemotactic responses to EGF in vitro and metastatic ability in vivo (21,22). Therefore, EGF receptor-mediated chemotaxis within the primary tumor may be important in enhancing invasion, intravasation, and metastasis in addition to the well-characterized effects of EGF receptor signaling on mitogenesis.…”